The €232 Million on Exor's Books: The Market Price Says Nothing About Juventus Losing Money

The July rain in Turin was barely falling, just enough to dampen the shoulders of my coat. I stood outside the gates of the Continassa training complex for nearly forty minutes, waiting for someone I already knew would not come. He works in finance, not in player representation. The appointment was cancelled with a three-word message. No new date was offered. Only silence.

Later that afternoon, Exor published its half-year results for 2026, the reporting period ending 30 June 2026. On the phone screen, a line scrolled past: the value of Exor's stake in Juventus had fallen from 789 million euros to 557 million euros. A difference of 232 million euros. Within the hour, football headlines across Europe were shouting, each in its own way, but all on the same beat: Juventus has lost 232 million euros.

I read that headline three times, then went back to the original filing. I remembered something I still tell young editors in Barcelona: I once believed in data, until Barcelona called. That lesson was the first of my career, and it still holds when I am reading a financial document two thousand kilometres from any pitch.

Exor is the holding company of the Agnelli-Elkann family, holding controlling stakes in a range of industrial and financial assets. Ferrari is the largest asset in that portfolio. Juventus sits at the edge of it.

The half-year filing contained a technical change that football headlines largely ignored. Exor's listed holdings are now recorded at market value, rather than under the equity method as before. When the Juventus share price moves on Borsa Italiana, the value of Exor's stake moves with it, regardless of whether the team wins or loses that weekend.

This is the crux the filing itself makes clear: the half-year change reflects share-price movement, not the operating result Juventus achieved. The switch to fair-value accounting did not rescue the club from anything, nor did it signal anything. It is simply a permitted, disclosed accounting position.

Put differently, 232 million euros is a valuation change on the stock market. It is not cash burned. It is not a club operating loss. It is not a wage cut, nor a torn-up contract.

Based on my experience covering Serie A matches across many seasons, I know one thing about Turin. People there are very good at reading a price board, and very bad at telling a price board apart from a league table.

Let's do the arithmetic the headline did not do.

In the first half of 2026, the value of Exor's Juventus stake fell by 232 million euros, from 789 million to 557 million, a decline of 29%. Over the same period, the value of its Ferrari stake rose by 213 million euros, from 12,037 million to 12,250 million, a gain of 3%.

Those two movements nearly cancel each other out. The net difference is roughly minus 19 million euros.

Yet Exor's net asset value per share fell 3.9% in the half-year, while the MSCI World index rose 11.8%. The relative gap is close to 15.7 percentage points. The MSCI World is the standard benchmark for global equities, and a gap of nearly 16 points in six months is something Exor's leadership must explain to shareholders. Juventus is not large enough to explain that gap.

That leads to a conclusion the headlines avoid: the decline in Exor's net asset value came mainly from other portfolio components, not from Juventus. At group scale, the Juventus stake is a small variable.

A ratio check: 557 million euros for Juventus against 12,250 million for Ferrari. Juventus is roughly 22 times smaller. In the language of a price board, a Juventus de-rating is portfolio noise.

Juventus did not lose 232 million euros in the first half of 2026. Exor recorded a 232 million euro decline in the value of its Juventus stake because of the share price, and at group scale that is a small variable. Those two sentences differ in substance, and the gap between them is the whole story.

I learned this after years standing between two worlds — the boardroom and the dressing room. The dressing room is the only place that bankrupts a transfer price board. But in the other direction, the price board is the only place that renders the dressing room meaningless in the eyes of investors.

There is a more reasonable question: if the Juventus share price fell 29% in six months, what is the market seeing?

The honest answer is that we do not know from this filing. There is no league table, no match result, no wage data, no expectation metric in Exor's disclosure showing what happened on the pitch.

Stock markets price expectations of the future. For a football club, those expectations usually revolve around four things: Champions League qualification and the revenue that comes with it, the risk of dilution from a capital increase, structural financial burdens, and the general mood of European football. A 29% decline is consistent with a combination of those factors, but this document proves none of them is the driver.

Italian football also carries a structural revenue gap against the Premier League. That gap does not vanish in six months, and it does not appear in a half-year filing. Anyone attributing the 29% decline to a single on-pitch cause is telling a story the data cannot carry.

I have made exactly this mistake. In 2026, aged 26, I received a tip from a fitness assistant at La Masia about a young player refusing a professional contract over a few hundred euros a week. I sat in my car for three hours outside the secondary training pitch to verify his behaviour after the session. The story was right, and I was the only one who ran it before Barcelona raised their offer. But in 2026 I wrote a long piece based on a single internal source about a star leaving Barcelona. It was pulled. I had to publish a correction. Since then I hold one rule: never infer a club's operating performance from its share price. The two boards move to different rhythms.

The real blind spot in this story sits in a sentence, not in a price decline.

In his remarks on the results, John Elkann, Exor's chief executive, spoke of the group's transformation continuing, of being satisfied with disposals already made, and of finding suitable owners for companies in the portfolio.

That is the language of someone restructuring a portfolio, not defending one. Football headlines focused on the 232 million euro decline and skipped that sentence. I did the opposite. A valuation can reverse within six months if market sentiment turns. A divestment strategy does not reverse that easily.

Notably, Elkann did not name Juventus. He did not say whether the club sits inside or outside the divestment plan. That gap carries its own meaning. In my trade, silence is always a form of information, and usually the most expensive kind.

There is a further technical wrinkle. When a listed asset is carried at market value, its volatility will appear in the parent's results every quarter, every half-year, indefinitely — whether the team is good or bad. For a listed holding, owning a football club this way creates reported earnings volatility without a matching financial benefit.

That is the technical reason a diversified group might want out of an asset like Juventus. It is not evidence that Exor is preparing to sell, but it is a rational argument anyone analysing ownership structures must weigh.

There is one more layer rarely discussed: the relationship between Exor and Juventus is a closely related-party arrangement. Exor is both controlling shareholder and the party that may have to fund a capital increase if the club needs one. In Serie A, a club of Juventus's profile has for a decade typically depended on capital increases backed by its largest shareholder. If that recurs, the dilution risk falls on minority shareholders, not on Exor.

And there is a question no headline asked: is Juventus competing for capital with Ferrari itself?

Inside a portfolio, every asset competes for management attention and scarce capital. Ferrari rose 3% while Juventus fell 29% in the same period. If I were allocating capital, I would know where to look.

This holds beyond Exor. Any club inside a diversified conglomerate faces comparison pressure against higher-returning siblings in the same portfolio. That is a structural disadvantage clubs owned by single private owners or sport-specific funds do not carry to the same degree.

What is worth tracking is not the 232 million euro decline. That figure will change, may recover, may deepen, and will reappear in the next reporting period and the one after, as long as Exor carries the stake at market value.

What is worth tracking is the next sentence Exor says, and the one it does not.

I stayed in Turin a few more days after that rainy afternoon. The person I was waiting for never came. But I realised I already had enough material to write, and the story is not that 232 million euros disappeared — it is that nobody asked where the money went, because under the meaning people assumed, it was never there.

In this trade I keep one principle: ESTP means walking down to the pitch, seeing it with your own eyes, and only then typing. But some matches are played in closed boardrooms, and there the only thing that lets you see clearly is the silence of someone who does not answer your message.